Recently, Warrant Pharmaceuticals(688799) Its wholly-owned subsidiary, Hunan Huana Pharmaceutical Chiral Drug Co., Ltd., successively received the " Chemical Raw Material " certificates for terbutaline sulfate and indocyanine green issued by the National Medical Products Administration.The drug marketing application approval notice, along with the formulation, received an "A" rating in the joint review and approval process, indicating that it meets the relevant national drug review technical standards and has been approved for use in domestic formulations.
According to reports, terbutaline sulfate is the raw material for preparations such as terbutaline sulfate nebulized inhalation solution.Terbutaline sulfate nebulized inhalation solution is mainly used to relieve bronchospasm associated with bronchial asthma, chronic bronchitis, emphysema, and other lung diseases.
Indocyanine green is the active pharmaceutical ingredient (API) for products such as injectable indocyanine green . Injectable indocyanine green, often referred to as "GPS on a knife's edge," is primarily used to diagnose various liver diseases, including cirrhosis, liver fibrosis, occupational and drug-induced liver disease, to assess the extent of liver damage and its reserve function; it is also used in choroidal angiography to determine the location of choroidal lesions.
Currently, Warrant Pharmaceuticals has obtained marketing authorization for terbutaline sulfate nebulized inhalation solution; according to the CDE website, indocyanine green for injection is also under review and approval.
Warrant Pharmaceuticals stated that the approval of the active pharmaceutical ingredients terbutaline sulfate and indocyanine green not only enriches the company's product line but also further solidifies the company's industrial advantage of "integrated raw materials and formulations" and enhances the company's core competitiveness.

Source: https://finance.eastmoney.com/a/202610193899639666.html